Mark W. Gelpi

Mark Gelpi practices at Mercy Health Physicians Cincinnati Specialty Care in Cincinnati, Ohio.

Mark Gelpi's NPI, 1821417056, was assigned on April 15, 2014. Mark Gelpi holds Ohio license 35.139527.

Mark Gelpi's primary practice is Mercy Health Physicians Cincinnati Specialty Care, at 3301 Mercy Health Blvd, Cincinnati, OH 45211 in Hamilton County. The practice phone is (888) 696-3541.

Mark Gelpi's primary practice is Mercy Health Physicians Cincinnati Specialty Care in Cincinnati, Ohio. Mark Gelpi is also affiliated with Mercy Health - West Hospital. The medical group on file is Mercy Health Physicians. Dmand AI also links Mark Gelpi to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Gelpi practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Mark Gelpi's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Mark Gelpi is licensed in Ohio.

CMS data shows 649 Medicare services from Mark Gelpi across 10 procedure codes in 2024, for 310 Medicare patients. Medicare paid $53,094 for them.

CMS counts 310 Medicare patients who saw Mark Gelpi in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mark Gelpi's median patient age at 66, with 59% women.

In 2024, Mark Gelpi wrote 894 Medicare Part D claims for 353 patients. 97% of them were for generic drugs. CMS names the drug for 779 of them, across 21 drugs with 11 or more claims each, at $11,364 in total drug cost. In 2023, CMS named 737 claims across 18 drugs.

Mark Gelpi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Mark Gelpi, published from 2019 to 2020. 2020 was the busiest year, with 4. The most frequent topics are Aerosols, COVID-19 and Endoscopy. Mark Gelpi has published most often in Am J Rhinol Allergy. Mark Gelpi's most frequent co-authors are Charles Stephen Ebert, MD, Adam Mikial Zanation, MD and Brent A. Senior, MD.

CMS Open Payments shows 33 general payments to Mark Gelpi from 13 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $1,368.